General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Vaccines and Diagnostics

Preventing diseases with innovative products

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Vaccine.


Reporting side effects

The Novartis Vaccines and Diagnostics Division provides more than 20 products to fight vaccine-preventable viral and bacterial diseases as well as sophisticated instruments, assays, reagents and software to test donated blood and blood products for infectious diseases before they are transfused to patients.

The division consists of two businesses:

Not all products are available in all countries. Regulatory requirements in various countries limit the product information that we can provide. Please consult your physician about any medical condition or product.

  • Agrippal

  • Begrivac

  • Optaflu

  • Flucelvax

  • Focetria

  • Fluad

  • Fluvirin

  • Bexsero

  • Menveo

  • Menjugate

  • IXIARO

  • Encepur N

  • RabAvert

  • Quinvaxem

  • Polioral